Corrigendum: Structural Influence on the Dominance of Virus-Specific CD4 T Cell Epitopes in Zika Virus Infection

Corrigendum: Structural Influence on the Dominance of Virus-Specific CD4 T Cell Epitopes in Zika Virus Infection

Bibliographic Details
Main Authors:	Maximilian Koblischke, Karin Stiasny, Stephan W. Aberle, Stefan Malafa, Georgios Tsouchnikas, Julia Schwaiger, Michael Kundi, Franz X. Heinz, Judith H. Aberle
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-09-01
Series:	Frontiers in Immunology
Subjects:	Zika virus flavivirus CD4 T cell immunodominance epitope Zika patients
Online Access:	https://www.frontiersin.org/article/10.3389/fimmu.2018.02083/full

Similar Items

Different Cross-Reactivities of IgM Responses in Dengue, Zika and Tick-Borne Encephalitis Virus Infections
by: Karin Stiasny, et al.
Published: (2021-03-01)

Identification of immunodominant T cell epitopes induced by natural Zika virus infection
by: Christopher S. Eickhoff, et al.
Published: (2023-08-01)

The CD8+ and CD4+ T Cell Immunogen Atlas of Zika Virus Reveals E, NS1 and NS4 Proteins as the Vaccine Targets
by: Hangjie Zhang, et al.
Published: (2022-10-01)

Zika Virus from the Perspective of Observational Studies: a Review
by: Tayyab Saleem, et al.
Published: (2023-02-01)

Zika virus: an alert for prevention
by: Deysi Licourt Otero, et al.
Published: (2018-05-01)

Zika Virus Seroprevalence, French Polynesia, 2014–2015
by: Maite Aubry, et al.
Published: (2017-04-01)

Strong CD4 T Cell Responses to Zika Virus Antigens in a Cohort of Dengue Virus Immune Mothers of Congenital Zika Virus Syndrome Infants
by: Catherine J. Reynolds, et al.
Published: (2020-02-01)

Zika virus: the latest newcomer
by: Juan-Carlos eSaiz, et al.
Published: (2016-04-01)

Zika Virus NS2A-Mediated Virion Assembly
by: Xianwen Zhang, et al.
Published: (2019-10-01)

Zika Virus Replicons for Drug Discovery
by: Xuping Xie, et al.
Published: (2016-10-01)

Previous dengue or Zika virus exposure can drive to infection enhancement or neutralisation of other flaviviruses
by: Renato AS Oliveira, et al.

A vaccine effective against Zika virus is theoretically possible but may not be delivered anytime soon
by: Taylor-Robinson AW
Published: (2016-07-01)

Zika virus infection: The resurgence of a neglected disease
by: Tushar Kambale, et al.
Published: (2016-01-01)

Zika virus as an emerging arbovirus of international public health concern
by: Samira Vaziri, et al.
Published: (2022-10-01)

Cell-active carbazole derivatives as inhibitors of the zika virus protease
by: Rassias, Gerasimos, et al.
Published: (2021)

An Approach for a Synthetic CTL Vaccine Design against Zika Flavivirus Using Class I and Class II Epitopes Identified by Computer Modeling
by: Edecio Cunha-Neto, et al.
Published: (2017-06-01)

Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans
by: Félix G. Delgado, et al.
Published: (2018-09-01)

Etymologia: Zika Virus
Published: (2014-06-01)

The latest advancements in Zika virus vaccine development
by: Lanying Du, et al.
Published: (2017-10-01)

Zika Virus Outside Africa
by: Edward B. Hayes
Published: (2009-09-01)

Microcefalia e Zika Vírus: características e associações
by: Cynthia Molina Bastos, et al.
Published: (2016-08-01)

Zika virus: Vaccine initiatives and obstacles
by: Reema Mukherjee, et al.
Published: (2017-01-01)

A new global threat for the public safety: Zika virus
by: Simona Bicheru, et al.
Published: (2016-04-01)

Attenuation of Zika Virus by Passage in Human HeLa Cells
by: Li Li, et al.
Published: (2019-08-01)

Human Claudin-Derived Peptides Block the Membrane Fusion Process of Zika Virus and Are Broad Flavivirus Inhibitors
by: Jim Zoladek, et al.
Published: (2022-10-01)

Zika Virus Infection, Cambodia, 2010
by: Vireak Heang, et al.
Published: (2012-02-01)

Zika Virus Inhibitors Based on a 1,3-Disubstituted 1<i>H</i>-Pyrazolo[3,4-<i>d</i>]pyrimidine-amine Scaffold
by: Eunkyung Jung, et al.
Published: (2022-09-01)

Current trends in Zika vaccine development
by: Francisco A. Lagunas-Rangel, et al.
Published: (2017-07-01)

Zika in travellers 1947-2017 : a systematic review
by: Wilder-Smith, Annelies, et al.
Published: (2020)

Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III
by: Yanling Wu, et al.
Published: (2017-01-01)

Corrigendum: Potent Restriction of Sexual Zika Virus Infection by the Lipid Fraction of Extracellular Vesicles in Semen
by: Ruofan Wang, et al.
Published: (2021-06-01)

Evidence of Zika Virus Infection in Pigs and Mosquitoes, Mexico
by: Daniel Nunez-Avellaneda, et al.
Published: (2021-02-01)

Broad Antiviral Activity of Ginkgolic Acid against Chikungunya, Mayaro, Una, and Zika Viruses
by: Dalkiria Campos, et al.
Published: (2020-04-01)

Zika vaccines and therapeutics: landscape analysis and challenges ahead
by: Annelies Wilder-Smith, et al.
Published: (2018-06-01)

Inactivation and Environmental Stability of Zika Virus
by: Janis A. Müller, et al.
Published: (2016-09-01)

Effects of Statin Combinations on Zika Virus Infection in Vero Cells
by: Erica Españo, et al.
Published: (2022-12-01)

Protective to a T: The Role of T Cells during Zika Virus Infection
by: Ryan D. Pardy, et al.
Published: (2019-08-01)

Structural basis of Zika virus helicase in recognizing its substrates
by: Hongliang Tian, et al.
Published: (2016-07-01)

Zika virus nonstructural protein 5 residue R681 is critical for dimer formation and enzymatic activity
by: Saw, Wuan-Geok, et al.
Published: (2021)

Seroprevalence of Zika Virus in Amphawa District, Thailand, after the 2016 Pandemic
by: Salin Sirinam, et al.
Published: (2022-02-01)